Search results
Results from the WOW.Com Content Network
Diagnosis of convergence insufficiency is made by an eye care professional skilled in binocular vision dysfunctions, such as an optometrist, ophthalmologist, or orthoptist to rule out any organic disease. Convergence insufficiency is characterized by one or more of the following diagnostic findings: patient symptoms, high exophoria at near ...
Specialty. Ophthalmology. Exotropia is a form of strabismus where the eyes are deviated outward. It is the opposite of esotropia and usually involves more severe axis deviation than exophoria. People with exotropia often experience crossed diplopia. Intermittent exotropia is a fairly common condition. "Sensory exotropia" occurs in the presence ...
Fusional amplitude and relative fusional amplitude training are designed to alleviate convergence insufficiency. The CITT study (Convergence Insufficiency Treatment Trial) was a randomized, double-blind multi-center trial (high level of reliability) indicating that orthoptic vision therapy is an effective method of treatment of convergence ...
Specialty. Cardiology. Chronic cerebrospinal venous insufficiency ( CCSVI or CCVI) is a term invented by Italian researcher Paolo Zamboni in 2008 to describe compromised flow of blood in the veins draining the central nervous system. [1] [2] Zamboni hypothesized that it might play a role in the cause or development of multiple sclerosis (MS).
Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes. [2] Symptoms include dryness in the eye, irritation, redness, discharge, blurred vision, and easily fatigued eyes. Symptoms range from mild and occasional to severe and continuous. [3]
Stargardt disease is the most common inherited single-gene retinal disease. [1] In terms of the first description of the disease, [2] it follows an autosomal recessive inheritance pattern, which has been later linked to bi-allelic ABCA4 gene variants (STGD1).
Treatment. If there is an underlying cause, treatment should be given based on the disease. Non specific treatment measures include cycloplegics, corticosteroids and immunosuppressive drugs. The biologic drugs that are currently used in treatment of panuveitis include anti tumor necrosis factor, cytokine receptor antibodies and interferon-α.
By Puyaan Singh and Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit's drug for a chronic inflammatory liver ...